PHASE-II STUDY OF 4 EPI-DOXORUBICIN

被引：12

作者：

FERRAZZI, E

NICOLETTO, O

VINANTE, O

PAGNIN, P

MARAGLINO, G

GANZINA, F

FIORENTINO, MV

机构：

[1] UNIV PADUA,OSPED CIVILE,DIV MED 3,I-35100 PADUA,ITALY

[2] UNIV PADUA,OSPED CIVILE,SERV CARDIOL,I-35100 PADUA,ITALY

[3] FARMITALIA,I-20146 MILAN,ITALY

来源：

TUMORI | 1982年 / 68卷 / 05期

关键词：

D O I：

10.1177/030089168206800513

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：431 / 435

页数：5

共 15 条

[1]

ARCAMONE F, 1975, CANCER CHEMOTH REP 3, V6, P123

[2] SYNTHESIS AND ANTITUMOR PROPERTIES OF NEW GLYCOSIDES OF DAUNOMYCINONE AND ADRIAMYCINONE [J].

ARCAMONE, F ;

PENCO, S ;

VIGEVANI, A ;

REDAELLI, S ;

FRANCHI, G ;

DIMARCO, A ;

CASAZZA, AM ;

DASDIA, T ;

FORMELLI, F ;

NECCO, A ;

SORANZO, C .

JOURNAL OF MEDICINAL CHEMISTRY, 1975, 18 (07) :703-707

[3] ADRIAMYCIN - NEW ANTICANCER DRUG WITH SIGNIFICANT CLINICAL ACTIVITY [J].

BLUM, RH ;

CARTER, SK .

ANNALS OF INTERNAL MEDICINE, 1974, 80 (02) :249-259

[4]

BONFANTE V, 1979, CANCER TREAT REP, V63, P915

[5]

CARTER SK, 1980, CANCER CHEMOTH PHARM, V4, P5

[6]

CASAZZA AM, 1979, CANCER TREAT REP, V63, P835

[7]

CASAZZA AM, 1978, CURRENT CHEMOTHERAPY, V2, P1257

[8]

COMIS RL, 1974, CANCER TREAT REV, V1, P285

[9]

GOTTLIEB JA, 1975, CANCER CHEMOTH REP 3, V6, P271

[10]

HOOGSTRATEN B, 1976, CANCER, V38, P13, DOI 10.1002/1097-0142(197607)38:1<13::AID-CNCR2820380104>3.0.CO

← 1 2 →